Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/2014
04/02/2014CN101563364B Insulinotropic peptide synthesis
04/02/2014CN101535336B Synthetic peptide amides and dimers thereof
04/02/2014CN101404979B Subcutaneous implants containing a degradation-resistant polylactide polymer and a LH-RH analogue
04/01/2014US8686223 Genetic transformation of jatropha curcas
04/01/2014US8686154 Compounds and compositions for delivering active agents
04/01/2014US8686120 DRG11-responsive (DRAGON) gene family
04/01/2014US8686117 Platelet aggregation inducing substance
04/01/2014US8686113 Antibiotic peptides
04/01/2014US8685955 Neuroprotective iron chelators and pharmaceutical compositions comprising them
04/01/2014US8685954 Methods and compositions for treating cancer using proteasome inhibitors
04/01/2014US8685934 Methods for treating extreme insulin resistance in patients resistant to previous treatment with other anti-diabetic drugs employing an SGLT2 inhibitor and compositions thereof
04/01/2014US8685933 Casein-derived peptides having anxiolytic activity
04/01/2014US8685932 Targeted transforming growth factor-beta-bound IgG for Treatment of Diseases
04/01/2014US8685931 Hair growth methods using FGFR3 extracellular domains
04/01/2014US8685930 Methods of providing therapeutic effects using cyclosporin components
04/01/2014US8685929 Detecting CYP24 expression level as a marker for predisposition to cancer
04/01/2014US8685928 Antagonists of MUC1
04/01/2014US8685927 Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolyzate
04/01/2014US8685925 Method and compositions for treating stroke with fever
04/01/2014US8685923 Fibrillar albumin for use in inhibiting cancer growth
04/01/2014US8685922 Template-fixed peptidomimetics with antimicrobial activity
04/01/2014US8685921 Inhibitors of beta integrin-G protein alpha subunit binding interactions
04/01/2014US8685919 Glucagon analogues
04/01/2014US8685918 Weight loss regimen comprising enteral and oral feeding segments effective for the treatment of obesity
04/01/2014US8685917 Cyclosporin analogues
04/01/2014US8685916 Opioid prodrugs with heterocyclic linkers
04/01/2014US8685914 L-alanyl-L-glutamine crystal
04/01/2014US8685752 Ex vivo flow cytometry method and device
04/01/2014US8685670 Isolated chimeric proteins of modified lumazine synthase
04/01/2014US8685664 Use of inhibtors of glutaminyl cyclases for treatment and prevention of disease
04/01/2014US8685662 Use of the α chain of brain spectrin and fragments thereof, for diagnosing cerebral diseases
04/01/2014US8685636 Heparin-insensitive method for determining direct coagulation factor inhibitors
04/01/2014US8685464 Composite bone graft substitute cement and articles produced therefrom
04/01/2014US8685445 Enteric composition for the manufacture of soft capsule wall
04/01/2014US8685426 Methods for making biocompatible, implantable, substantially sericin free silk fabric
04/01/2014US8685414 Method for the treatment of infraorbital dark circles using botulinum toxins
04/01/2014US8685411 Rotavirus antigens
04/01/2014US8685404 Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
04/01/2014US8685399 PAX 5 monoclonal antibody
04/01/2014US8685397 Combination therapy for the treatment of ocular neovascular disorders
04/01/2014US8685392 Rothia species glutamine endopeptidases and use thereof
04/01/2014US8685391 Skin care compositions
04/01/2014US8685384 Recombinant cancer cell secreting modified heat shock protein-antigenic peptide complex
04/01/2014US8685383 Protein-polymer-drug conjugates
04/01/2014US8685372 Peptides and aptamers for targeting of neuron or nerves
04/01/2014CA2708549C Bmp mutants with decreased susceptibility to noggin
04/01/2014CA2687141C Compositions and methods for producing bioactive fusion proteins
04/01/2014CA2604967C Pyrimidine derivatives and their use as p2y12 receptor antagonists
04/01/2014CA2597191C Antimicrobial hexapeptides
04/01/2014CA2577632C Intestinal epithelial glucose sensor
04/01/2014CA2564169C Methods for preventing or treating bone disorders
04/01/2014CA2531231C Uranium-chelating peptides and uses thereof
04/01/2014CA2504920C Ligand for g-protein coupled receptor fprl2 and uses thereof
04/01/2014CA2493928C Nucleic acids and corresponding proteins entitled 273p4b7 useful in treatment and detection of cancer
04/01/2014CA2488682C Gene differentially expressed in breast and bladder cancer and encoded polypeptides
04/01/2014CA2488677C Method of inhibiting prostate cancer cell proliferation
04/01/2014CA2486483C Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
04/01/2014CA2465792C Non-neurotoxic plasminogen activating factors for treating of stroke
04/01/2014CA2455490C Delivery of dsrna to arthropods
04/01/2014CA2420062C Erbb4 antagonists
04/01/2014CA2413354C Neurotoxic a.beta. oligomers in alzheimer's disease
04/01/2014CA2372441C Instant formulations of enzymes, used for animal feed
03/2014
03/27/2014WO2014047546A2 Use of mir-494 to modulate trail-induced apoptosis through bim down-regulation
03/27/2014WO2014047246A1 Systems, compositions and methods for the treatment of alopecia
03/27/2014WO2014047194A1 Antagonist for (pro)renin receptor for the treatment of hypertension and diabetes
03/27/2014WO2014047085A2 Prostate-specific tumor antigen and uses thereof
03/27/2014WO2014046753A2 Method and system for treatment of biological tissue
03/27/2014WO2014046732A1 Cyclotide-based cxcr4 antagonists with anti-hiv activity
03/27/2014WO2014046731A1 Preparation of cyclotides
03/27/2014WO2014046624A1 A method for treating a disease or disorder of the lung by inhibition of the hedgehog pathway
03/27/2014WO2014046490A1 Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
03/27/2014WO2014046478A1 Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
03/27/2014WO2014046415A1 Method for preparing in situ-formed hydrogel using enzyme-immobilized support, and biomedical use thereof
03/27/2014WO2014046247A1 Synthetic peptide for adjusting balance of type-1 tnf receptors and type-2 tnf receptors, and use of said peptide
03/27/2014WO2014045621A1 Pneumococcal vaccine containing pneumococcal surface protein a
03/27/2014WO2014045582A1 Sperm activating agent and activating method using same
03/27/2014WO2014045296A2 Improved daptomycin injectable formulation
03/27/2014WO2014045213A1 Stable pharmaceutical composition, comprising an aqueous solution of an antibody-derived therapeutically active protein
03/27/2014WO2014045126A2 Treatment of pain by inhibition of usp5 de-ubiquitinase
03/27/2014WO2014045081A1 Stable pharmaceutical composition, comprising an aqueous solution of an antibody-derived therapeutically active protein
03/27/2014WO2014044758A1 Novel il-17a binding molecules and medical uses thereof
03/27/2014WO2014044281A1 Inhibition of a 33-mer gliadin peptide for treatment of diabetes
03/27/2014WO2014043871A1 Use of pedf-derived polypeptides for treating osteoarthritis
03/27/2014WO2014043861A1 Use of pedf-derived polypeptides for preventing and/or ameliorating skin aging
03/27/2014WO2014043792A1 Glucosamine pro-drugs
03/27/2014WO2014022185A3 Method to treat or prevent herpesvirus infections
03/27/2014WO2014020130A3 Albumin composition
03/27/2014WO2014004376A3 Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereof
03/27/2014WO2013184614A3 Peptide conjugates for treating pain
03/27/2014WO2013177593A3 Identification of mhc class i phospho-peptide antigens from breast cancer utilizing shla technology and complementary enrichment strategies
03/27/2014WO2013170077A3 V1a receptor agonists
03/27/2014WO2013151744A9 Materials and methods for treatment of cystic fibrosis and for induction of ion secretion
03/27/2014WO2013096335A8 ADMINISTRATION OF AN ANTAGONIST OF α5β1 FOR ANTI-ANTIOGENESIS AND CANCER TREATMENT
03/27/2014WO2013036383A8 Oral delivery for hemoglobin based oxygen carriers
03/27/2014WO2012012518A3 Inhibition of nonsense mediated decay pathways
03/27/2014WO2011163572A3 Bifunctional conjugate compositions and associated methods
03/27/2014WO2011090971A3 Osteocalcin as a treatment for male reproductive disorders
03/27/2014US20140088502 Multi-Needle Injection Apparatus and System for Delivering Pharmacological Agents to Biological Tissue
03/27/2014US20140088176 Gene transfer for regulating smooth muscle tone
03/27/2014US20140088023 sGCalpha1 Inhibiting Compositions, and Methods of Treatment of Cancers Therewith
1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 3163